Latest news

SPCC Webinar Series – 12 April: What is efficiency in cancer care in Australia

The next SPCC webinar taking place on 12 April 2021 will discuss “What is efficiency in cancer care in Australia”. Among the speakers will be Prof. Christobel Saunders of University…

New video: Harnessing data for better cancer care

As part of a research project examining the role of driving efficiency in cancer care, All.Can has launched a video on the importance of data to patients and clinicians, and…

Call for contributions to the Efficiency Hub

All.Can has launched a new campaign on social media, encouraging the cancer community to share examples of best practice in cancer care via the All.Can Efficiency Hub.

#DrivingEfficiencyinCancerCare

All.Can Feedback on the European Health Data Space

All.Can welcomes the European Health Data Space (EHDS) initiative which seeks to ensure access and optimal use of health data as well as digital health products and services.  Efficient healthcare…

All.Can World Cancer Day Statement

Ahead of World Cancer Day on 4 February 2021, All.Can has published a statement calling for sustainable cancer care policies that give the greatest benefit to patients and value to the wider system.

New All.Can National Initiative in Israel

All.Can International is pleased to welcome All.Can Israel as its 18th national initiative.  All.Can Israel will aim to connect diverse stakeholders to identify ways to optimize the efficiency of cancer…

New All.Can National Initiative in Colombia

All.Can International is pleased to welcome a new national initiative in Colombia. The newly established initiative will structure its 2021 plan of activities around two working packages based on research…

All.Can Media Coverage – Korea Biomedical Review

‘Efficient cancer care meeting highest patient needs produce best treatment results’ Read the article and interview  (link here) with All.Can CEO Eduardo Pisani  that was published on 15 January 2021…

New All.Can National Initiative in Korea

All.Can Korea is the first Asian branch of All.Can International, consisting of patient advocacy groups, healthcare professionals, public health policy experts, legal counsellor, and an industry partner, BMS Pharmaceuticals Korea Ltd. On…